# LLM call: summary

- Turn: 6
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 730
- Completion tokens: 241
- Total tokens: 971
- Cost (USD): 0.000121

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1062: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By December European dependence deepened despite continuity working: a new US generalizing system obsoleted July timelines, while tailored oncology moved to practice with striking remissions but reached Europe mainly via US pipes — HERA's EU-hosted pilot covered only two indications reliably as other waiting lists grew.

The continuity reserve kept wards/ministries on vetted narrower assistants tied to Digital Europe continuity plans, with two hospital groups and three municipalities showing measured backlog falls credited to planning. A new interpretability method predicting some failures gave evaluators slightly beyond behaviour-grading.

Unity cracked when a large member state signed its own US hyperscaler compute-and-access deal with export-control side understandings, seen by Paris, Warsaw and Commission as a separate peace. Gigafactories inched ahead on two sites with brokered power and spares against shipping/Taiwan risk. Washington elected a coalition-minded president promising structured allied access, not yet priced.

CURRENT NARRATIVE:
### The ward and the world
Spring began with hope. Tailored cancer therapies posted remissions once thought impossible, and Brussels claimed a share: the EU-hosted pilot held steady on its two indications, and the continuity reserve kept wards running on narrower, checkable assistants. Washington's new administration took office promising structured allied access on published terms, and European capitals queued for clarity.

Then the tightening came. New chip and model export rules from Washington kept allied buyers on volume licences but fenced everyone else off, lifting prices and paperwork for the two gigafactory sites. Site managers with brokered power and stockpiled spares kept digging, but deliveries slipped by weeks.

### A recommendation no one can explain
In April a restored hospital network using a vetted reserve assistant reported the case that defined the half-year: an unexplainable recommendation that harmed patients. Traces were retained but illegible, liability crossed borders, and nightly coverage asked why blind models were allowed near bedsides.

The Commission pulled the module, shifted wards to narrower assistants under filed continuity plans, and pushed hospitals and municipalities to publish backlog figures to prove the rest still worked. Health ministers agreed mandatory incident reporting through the EU health emergency body and interim compensation from reserve funds, while evaluators applied the new failure-prediction method to certify re-deployment.

It contained the crisis without ending it. Trust in clinical assistants fell sharply, oncologists warned waiting lists for US-piped therapies were now a political fact, and the large member state with its own hyperscaler deal only slowly returned to common terms. Europe ended June treated, shaken, and still dependent — but with its building programme intact.
```

## Raw response

```
By June European dependence persisted despite continuity holding: tailored oncology posted striking remissions but reached Europe mainly via US pipes, with the EU-hosted pilot steady on only two indications as other waiting lists became a political fact.

A harmed-patients case from an unexplainable recommendation by a vetted reserve assistant defined spring: traces illegible, liability cross-border. Commission pulled the module, shifted wards to narrower assistants under filed continuity plans, mandated incident reporting via EU health emergency body with interim compensation from reserves, and required published backlog figures; evaluators used the new failure-prediction method to certify re-deployment. Trust in clinical assistants fell sharply.

Washington's new coalition-minded administration promised structured allied access on published terms, but new chip/model export rules kept allies on volume licences, raising prices/paperwork and slipping the two gigafactory sites by weeks despite brokered power and spares. The large member state with its own US hyperscaler deal only slowly returned to common terms. Building programme intact, but treated, shaken, still dependent.
```
